TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive OMB Specifies One Year Only Funding for 200 grants Under Supplemental Appropriations Level of 6,200 September 6, 1985
TCL Archive Pittsburgh Investigates Use of Resources in Anonymous Mailing To Researchers April 29, 1994
TCL Archive In Brief: New Clinical Education Program Guidelines Due; Maryland Has First Mammography Screening Law May 30, 1986
